Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,760.00
-410.00 (-5.02%)
At close: Oct 8, 2026

Hyundai Pharmaceutical Market Cap

Hyundai Pharmaceutical has a market cap or net worth of 214.78 billion as of October 9, 2026. It is the 22,354th most valuable company in the world and the 845th biggest in South Korea. Its market cap has increased by 100.52% in one year.

Market Cap
214.78B
Enterprise Value
n/a
Revenue
108.14B
Global Rank
Country Rank
#845 South Korea
PE Ratio
128.61

Chart

Chart

Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 214.78B, an increase of 646.41%. That is a compound annual growth rate of 6.67%.

History

DateMarket Cap% Change
Oct 8, 2026214.78B-8.92%
Dec 30, 2025235.81B137.66%
Dec 30, 202499.22B-12.77%
Dec 28, 2023113.76B-14.20%
Dec 29, 2022132.58B-19.22%
Dec 30, 2021164.12B-22.93%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
Korea United Pharm255.22B
Samjin Pharmaceuticals246.38B
Suheung225.51B
AptaBio Therapeutics223.06B
Huons221.38B
BNC KOREA209.29B
FutureChem Co.,Ltd189.42B
Yungjin Pharm.189.29B
Market Cap Rankings